Nirsevimab Protects Infants Against RSV-Linked Hospitalization
Nirsevimab efficacious for preventing RSV-associated lower respiratory tract infection and very severe RSV-associated LRTI
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.